APA (7th ed.) Citation

Varga, Z., Sinn, P., & Seidman, A. D. (2019). Summary of head-to-head comparisons of patient risk classifications by the 21-gene Recurrence Score® (RS) assay and other genomic assays for early breast cancer. International journal of cancer, 145(4), . https://doi.org/10.1002/ijc.32139

Chicago Style (17th ed.) Citation

Varga, Zsuzsanna, Peter Sinn, and Andrew D. Seidman. "Summary of Head-to-head Comparisons of Patient Risk Classifications by the 21-gene Recurrence Score® (RS) Assay and Other Genomic Assays for Early Breast Cancer." International Journal of Cancer 145, no. 4 (2019). https://doi.org/10.1002/ijc.32139.

MLA (9th ed.) Citation

Varga, Zsuzsanna, et al. "Summary of Head-to-head Comparisons of Patient Risk Classifications by the 21-gene Recurrence Score® (RS) Assay and Other Genomic Assays for Early Breast Cancer." International Journal of Cancer, vol. 145, no. 4, 2019, https://doi.org/10.1002/ijc.32139.